Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BackgroundEconomic growth in low- and middle-income countries (LMIC) has raised interest in how disease burden patterns are related to economic development. Meanwhile, poverty-related diseases are considered to be neglected in terms of research and development (R&D).ObjectivesDeveloping intuitive and meaningful metrics to measure how different diseases are related to poverty and neglected in the current R&D system.DesignWe measured how diseases are related to economic development with the income relation factor (IRF), defined by the ratio of disability-adjusted life-years (DALYs) per 100,000 inhabitants in LMIC versus that in high-income countries. We calculated the IRF for 291 diseases and injuries and 67 risk factors included in the Global Burden of Disease Study 2010. We measured neglect in R&D with the neglect factor (NF), defined by the ratio of disease burden in DALYs (as percentage of the total global disease burden) and R&D expenditure (as percentage of total global health-related R&D expenditure) for 26 diseases.ResultsThe disease burden varies considerably with the level of economic development, shown by the IRF (median: 1.38; interquartile range (IQR): 0.79-6.3). Comparison of IRFs from 1990 to 2010 highlights general patterns of the global epidemiological transition. The 26 poverty-related diseases included in our analysis of neglect in R&D are responsible for 13.8% of the global disease burden, but receive only 1.34% of global health-related R&D expenditure. Within this group, the NF varies considerably (median: 19; IQR: 6-52).ConclusionsThe IRF is an intuitive and meaningful metric to highlight shifts in global disease burden patterns. A large shortfall exists in global R&D spending for poverty-related and neglected diseases, with strong variations between diseases.

Original publication

DOI

10.3402/gha.v8.25818

Type

Journal article

Journal

Global health action

Publication Date

22/01/2015

Volume

8

Addresses

Faculty of Medicine, Technische Universität München, Munich, Germany; Universities Allied for Essential Medicines Europe e.V. (UAEM), Berlin, Germany; peter.philipsborn@alumni.lse.ac.uk.

Keywords

Humans, Wounds and Injuries, Risk Factors, Biomedical Research, Developing Countries, Poverty, Socioeconomic Factors, World Health Organization, Economic Development, Neglected Diseases, Global Health